Eli Lilly (LLY) announced results from the VIVID-2 open-label extension study, which showed the majority of patients with moderately to ...

TransCode Therapeutics (RNAZ) announced that Cohort 3 of its Phase 1 clinical trial enrolled three patients and all have been dosed with ...

Wade McKoy has photographed Jackson's best skiers, storms, and moments over nearly five decades. His best shots and stories ...

Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...

A set of 5844 free MIT-licensed high-quality SVG icons for you to use in your web projects. Each icon is designed on a 24x24 grid and a 2px stroke. If you load an icon as an image, you can modify its ...

Some foods are all about the moment—you have to enjoy them fresh, or they lose their magic. Then there are the patient ones, ...

Still coping with President Trump’s directive barring transgender people from serving in the military, LGBTQ advocates on ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Qalsody (tofersen) halted disease progression and improved functional independence and mobility in people with amyotrophic lateral sclerosis (ALS) who received the treatment in a real-world setting, ...

This study aimed to explore distinct SOC profiles among caregivers of breast cancer patients, identify the distribution differences of these profiles in sociodemographic and clinical characteristics, ...

Medicare patients referred to a neurologist had to wait a median of 34 days before being seen, and nearly 1 in 5 patients waited more than 90 days, in 2018 and 2019, according to a study published ...

About 30 per cent of patients who require hospital admission are still waiting in emergency eight hours after arrival, according to the Australasian College for Emergency Medicine. Long wait ...